Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-18

Clinical Trial Update: Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the effects of ezetimibe on kidney fat in type 2 diabetes with diabetic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Diabetes Mellitus, Type 2, Diabetic Kidney Disease | Phase 3 | Status: UNKNOWN